GlassScriptPhysician profile
Ihab A Al Shelli
NPI 1932492048
$20,562.24
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,407 · 2020: $238 · 2021: $284 · 2022: $12K · 2023: $5,787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,118 · Food and Beverage: $975 · Travel and Lodging: $514 · Gift: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,117.68 |
| Food and Beverage | $975.12 |
| Travel and Lodging | $513.80 |
| Gift | $180.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,860.05 | 2022-2023 | Da Vinci Surgical System |
| Pulmonx Corporation | $1,000.56 | 2019-2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Veran Medical Technologies, INC. | $748.28 | 2019 | |
| Glaxosmithkline, LLC. | $597.81 | 2019-2023 | Trelegy Ellipta |
| Pinnacle Biologics, INC | $300.00 | 2022 | |
| Csa Medical, INC | $197.86 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.06 | 2019-2023 | Ofev |
| Boston Scientific Corporation | $147.53 | 2020-2023 | Exalt Model D |
| Getinge USA Sales, LLC | $142.86 | 2019 | |
| Grifols USA, LLC | $82.60 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $70.04 | 2023 | Uptravi, Opsumit |
| Genentech USA, INC. | $68.70 | 2019 | |
| Genzyme Corporation | $43.67 | 2022 | |
| Mylan Specialty L.P. | $40.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $21.37 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $19.78 | 2022 | |
| Covidien LP | $17.08 | 2020 | |
| Novartis Pharmaceuticals Corporation | $16.49 | 2019 | |
| Philips North America LLC | $14.11 | 2023 | |
| Sandoz INC. | $12.39 | 2019 | |
| Erbe USA INC | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ihab Al Shelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.